Application of the PharmPrint methodology to two protein kinases.
Deanda
Felix
F
Computational, Analytical, and Structural Sciences, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina 27709, USA. Felix.G.Deanda@gsk.com
Stewart
Eugene L
EL
D042846:CDC2-CDC28 Kinases / Q000037:antagonists & inhibitors; D051357:Cyclin-Dependent Kinase 2; D011494:Protein Kinases / Q000737:chemistry*; D021281:Quantitative Structure-Activity Relationship; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000037:antagonists & inhibitors
D011494:Protein Kinases; D040301:Vascular Endothelial Growth Factor Receptor-2; D042846:CDC2-CDC28 Kinases; D051357:Cyclin-Dependent Kinase 2